P. Leif Bergsagel

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

Shaji Kumar, J H Lee, Juan José Lahuerta et al. · Leukemia · 2011 · 721 citations

Medicine, Hematology, Pharmacotherapy +15

Genetics and Cytogenetics of Multiple Myeloma

Rafaël Fonseca, Bart Barlogie, Régis Bataille et al. · Cancer Research · 2004 · 686 citations

Medicine, Genetics, Molecular Genetics +17

Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial

Craig B. Reeder, Donna Reece, Vishal Kukreti et al. · Leukemia · 2009 · 371 citations · Full text

Medicine, Hematology, Oncology +15

Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2

Nikhil C. Munshi, Kenneth C. Anderson, P. Leif Bergsagel et al. · Blood · 2011 · 315 citations · Full text

Medicine, Hematology, Oncology +16

International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation

Michèle Cavo, S. Vincent Rajkumar, Antonio Palumbo et al. · Blood · 2011 · 314 citations · Full text

Medicine, Hematology, Oncology +16